222 related articles for article (PubMed ID: 14668029)
1. Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.
Dorsam RT; Murugappan S; Ding Z; Kunapuli SP
Hematology; 2003 Dec; 8(6):359-65. PubMed ID: 14668029
[No Abstract] [Full Text] [Related]
2. Impact of chronic kidney disease on platelet P2Y
Engwenyu LR; Franchi F; Rollini F; Cho JR; DeGroat C; Bhatti M; Alobaidi Z; Ferrante E; Jakubowski JA; Sugidachi A; Zenni M; Bass TA; Angiolillo DJ
Thromb Haemost; 2017 Jan; 117(1):201-203. PubMed ID: 27786340
[No Abstract] [Full Text] [Related]
3. Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model.
Ravnefjord A; Weilitz J; Emanuelsson BM; van Giezen JJ
Thromb Res; 2012 Oct; 130(4):622-8. PubMed ID: 22909827
[TBL] [Abstract][Full Text] [Related]
4. Regulators of platelet cAMP levels: clinical and therapeutic implications.
Noé L; Peeters K; Izzi B; Van Geet C; Freson K
Curr Med Chem; 2010; 17(26):2897-905. PubMed ID: 20858171
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
[TBL] [Abstract][Full Text] [Related]
6. Advances in the monitoring of anti-P2Y12 therapy.
Harrison P
Platelets; 2012; 23(7):510-25. PubMed ID: 22916724
[TBL] [Abstract][Full Text] [Related]
7. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
8. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
9. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
[TBL] [Abstract][Full Text] [Related]
10. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
Makkawi M; Howells D; Wright MD; Jackson DE
Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
[TBL] [Abstract][Full Text] [Related]
11. Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
Geara AS; Ayoub I; Abi Rached J; Siddique MN; Ghimire P; El-Sayegh S
Am J Cardiol; 2011 Apr; 107(7):1103-4. PubMed ID: 21419895
[No Abstract] [Full Text] [Related]
12. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
13. Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease.
Ueno M; Ferreiro JL; Tomasello SD; Capodanno D; Tello-Montoliu A; Kodali M; Seecheran N; Dharmashankar K; Alissa R; Capranzano P; Desai B; Charlton RK; Bass TA; Angiolillo DJ
Thromb Haemost; 2011 Apr; 105(4):730-2. PubMed ID: 21225097
[No Abstract] [Full Text] [Related]
14. The H(2)-receptor antagonist ranitidine interferes with clopidogrel-mediated P2Y(12) inhibition in platelets.
Schäfer A; Flierl U; Pförtsch S; Seydelmann N; Micka J; Bauersachs J
Pharmacol Res; 2010 Oct; 62(4):352-6. PubMed ID: 20595015
[TBL] [Abstract][Full Text] [Related]
15. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
[TBL] [Abstract][Full Text] [Related]
16. Prasugrel resistance: fact or fiction.
Alexopoulos D
Platelets; 2012; 23(2):83-90. PubMed ID: 21787175
[TBL] [Abstract][Full Text] [Related]
17. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Badr Eslam R; Lang IM; Kaider A; Panzer S
Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
[TBL] [Abstract][Full Text] [Related]
18. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
Cattaneo M
Blood; 2011 Feb; 117(7):2102-12. PubMed ID: 20966167
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of action for reversible P2Y12 antagonists.
Liu H; Ge H; Peng Y; Xiao P; Xu J
Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of P2Y₁₂ reduces physiological thromboxane levels.
Bhavaraju K; Georgakis A; Jin J; Gartner TK; Tomiyama Y; Nurden A; Nurden P; Kunapuli SP
Platelets; 2010; 21(8):604-9. PubMed ID: 21067313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
